James E. Levine, Chief Financial Officer at Cidara Therapeutics, Inc. (CDTX), bought 100,000 shares at $2.01 ($201K) on 2020-11-10, disclosed to the SEC on 2020-11-12.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.01 | 50,000 | $100K | 50.0% |
| 2 | $2.01 | 50,000 | $101K | 50.0% |
| Total | $2.01 avg | 100,000 | $201K | 100% |
| Filing → |
| CRDF | BUY | 2021-09-13 | $194K | — | Filing → |
| CDTX | BUY | 2020-03-23 | $57K | — | Filing → |
| VRNM | BUY | 2012-05-16 | $18K | — | Filing → |